Related Experiment Video
Updated: May 11, 2026

11:59
Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
Chimerism analysis following hematopoietic stem cell transplantation
1ProPath Services, Dallas, TX, USA.
Methods in Molecular Biology (Clifton, N.J.)
|May 14, 2013
Summary
Allogeneic hematopoietic stem cell transplantation (HSCT) monitoring uses short tandem repeat (STR) analysis to track donor engraftment and disease recurrence. This cost-effective PCR and capillary electrophoresis method ensures sensitive chimerism assessment post-transplant.
Area of Science:
- Hematology
- Transplantation immunology
- Molecular biology
Background:
- Allogeneic hematopoietic stem cell transplantation (HSCT) is a vital treatment for hematological disorders.
- Chimerism analysis is crucial for evaluating HSCT success, including donor engraftment, graft rejection, and minimal residual disease.
- Current standard for chimerism monitoring involves PCR amplification of short tandem repeat (STR) loci followed by capillary electrophoresis.
Purpose of the Study:
- To describe the utility of chimerism studies in assessing outcomes after HSCT.
- To highlight the effectiveness of STR analysis for monitoring donor engraftment and disease status.
- To emphasize the role of chimerism monitoring in managing patients post-HSCT.
Main Methods:
- Selection of informative STR loci differentiating donor and recipient prior to HSCT.
- Analysis of post-transplant specimens using PCR amplification of selected STR loci.
- Quantification of donor and recipient percentages via capillary electrophoresis.
Main Results:
- STR analysis provides sensitive detection of chimerism.
- The method allows for accurate calculation of donor and recipient cell percentages.
- This approach is effective in monitoring key indicators of HSCT success.
Conclusions:
- STR-based chimerism analysis is a rapid, sensitive, and cost-effective method for post-HSCT monitoring.
- This technique aids in assessing donor engraftment, graft rejection, and minimal residual disease.
- Chimerism studies are indispensable for optimal patient management following HSCT.

